KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Comparison Results
KalVista Pharmaceuticals
€17.38
€873.93M
-37.98
78.78%
7 Buy
0 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$11.17
$714.44M
-9.53
65.97%
8 Buy
6 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$5.40
$981.48M
-12.74
211.43%
9 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.61
$1.44B
-6.67
111.35%
8 Buy
2 Hold
0 Sell
Strong Buy
Performance Comparison
DE:4XC1
KalVista Pharmaceuticals
16.09
6.54
68.48%
SVRA
Savara
5.87
3.23
122.35%
ARVN
Arvinas Holding Company
11.17
4.55
68.73%
GOSS
Gossamer Bio
0.37
-0.41
-52.25%
CMPX
Compass Therapeutics
5.45
3.80
230.30%
BCAX
Bicara Therapeutics Inc.
21.98
11.83
116.55%